Guo-Li Wang

528 total citations
10 papers, 417 citations indexed

About

Guo-Li Wang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Guo-Li Wang has authored 10 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Guo-Li Wang's work include Endoplasmic Reticulum Stress and Disease (3 papers), Cancer-related Molecular Pathways (3 papers) and Ubiquitin and proteasome pathways (2 papers). Guo-Li Wang is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (3 papers), Cancer-related Molecular Pathways (3 papers) and Ubiquitin and proteasome pathways (2 papers). Guo-Li Wang collaborates with scholars based in United States, Russia and Germany. Guo-Li Wang's co-authors include Nikolai A. Timchenko, Elizabeth Salisbury, Xiurong Shi, Lubov Timchenko, Estela E. Medrano, Jingling Jin, Roy G. Smith, Jeffrey H. Albrecht, Yuxiang Sun and Ralf Krahe and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Molecular and Cellular Biology.

In The Last Decade

Guo-Li Wang

10 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo-Li Wang United States 10 305 80 73 65 57 10 417
Kurt Jungermann Germany 11 173 0.6× 29 0.4× 63 0.9× 53 0.8× 50 0.9× 14 359
Mariapia Viola-Magni Italy 13 231 0.8× 23 0.3× 33 0.5× 36 0.6× 62 1.1× 28 351
S Schwartz Israel 7 340 1.1× 28 0.3× 36 0.5× 32 0.5× 53 0.9× 7 462
Fabián Arenas Spain 9 154 0.5× 27 0.3× 134 1.8× 112 1.7× 146 2.6× 20 485
Rupen Amin United States 4 193 0.6× 22 0.3× 40 0.5× 31 0.5× 131 2.3× 5 332
María García‐Barcina Spain 11 131 0.4× 32 0.4× 19 0.3× 39 0.6× 24 0.4× 17 313
PL Weissberg United Kingdom 9 270 0.9× 47 0.6× 13 0.2× 27 0.4× 21 0.4× 19 432
Keara L. Redmond United Kingdom 9 310 1.0× 67 0.8× 18 0.2× 28 0.4× 205 3.6× 11 510
Nobuaki Funahashi Japan 9 206 0.7× 48 0.6× 11 0.2× 43 0.7× 23 0.4× 20 341

Countries citing papers authored by Guo-Li Wang

Since Specialization
Citations

This map shows the geographic impact of Guo-Li Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo-Li Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo-Li Wang more than expected).

Fields of papers citing papers by Guo-Li Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo-Li Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo-Li Wang. The network helps show where Guo-Li Wang may publish in the future.

Co-authorship network of co-authors of Guo-Li Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guo-Li Wang. A scholar is included among the top collaborators of Guo-Li Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo-Li Wang. Guo-Li Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Guo-Li, Jing Wang, Ganka Douglas, et al.. (2011). Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis. Molecular Genetics and Metabolism. 103(4). 349–357. 23 indexed citations
2.
Wang, Guo-Li, Xiurong Shi, Simon Haefliger, et al.. (2010). Elimination of C/EBPα through the ubiquitin-proteasome system promotes the development of liver cancer in mice. Journal of Clinical Investigation. 120(7). 2549–2562. 50 indexed citations
3.
Salisbury, Elizabeth, Benedikt Schoser, Christiane Schneider‐Gold, et al.. (2009). Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients. American Journal Of Pathology. 175(2). 748–762. 70 indexed citations
4.
Jin, Jingling, Guo-Li Wang, Elizabeth Salisbury, Lubov Timchenko, & Nikolai A. Timchenko. (2009). GSK3β-cyclin D3-CUGBP1-eIF2 pathway in aging and in Myotonic Dystrophy. Cell Cycle. 8(15). 2356–2359. 17 indexed citations
5.
Jin, Jingling, Guo-Li Wang, Lubov Timchenko, & Nikolai A. Timchenko. (2009). GSK3β and aging liver. Aging. 1(6). 582–585. 23 indexed citations
6.
Wang, Guo-Li, Xiurong Shi, Elizabeth Salisbury, & Nikolai A. Timchenko. (2008). Regulation of apoptotic and growth inhibitory activities of C/EBPα in different cell lines. Experimental Cell Research. 314(7). 1626–1639. 27 indexed citations
7.
Wang, Guo-Li, Elizabeth Salisbury, Xiurong Shi, et al.. (2008). HDAC1 Promotes Liver Proliferation in Young Mice via Interactions with C/EBPβ. Journal of Biological Chemistry. 283(38). 26179–26187. 50 indexed citations
8.
Wang, Guo-Li, Elizabeth Salisbury, Xiurong Shi, et al.. (2008). HDAC1 Cooperates with C/EBPα in the Inhibition of Liver Proliferation in Old Mice. Journal of Biological Chemistry. 283(38). 26169–26178. 75 indexed citations
9.
Wang, Guo-Li, Xiurong Shi, Elizabeth Salisbury, et al.. (2006). Growth Hormone Corrects Proliferation and Transcription of Phosphoenolpyruvate Carboxykinase in Livers of Old Mice via Elimination of CCAAT/Enhancer-binding Protein α-Brm Complex. Journal of Biological Chemistry. 282(2). 1468–1478. 29 indexed citations
10.
Wang, Guo-Li, Xiurong Shi, Elizabeth Salisbury, et al.. (2006). Cyclin D3 Maintains Growth-Inhibitory Activity of C/EBPα by Stabilizing C/EBPα-cdk2 and C/EBPα-Brm Complexes. Molecular and Cellular Biology. 26(7). 2570–2582. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026